Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ASTRAZENECA K.K.

Home Clinical Trial Sponsors and OrganizationsASTRAZENECA K.K.

ASTRAZENECA K.K.

3-1, OFUKACHO, KITA-KU, Osaka, Japan

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

181

51 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

16

8.8%

Phase 3

16

8.8%

Phase 1

6

3.3%

Phase 1/2

1

0.6%

Trial Status Distribution

Active, not recruiting

46

25.4%

Completed

63

34.8%

Not yet recruiting

5

2.8%

Recruiting

67

37.0%

Clinical Trials

Trials sponsored by this organization (181)

A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Co-administration of AZD9550 and AZD6234 in Participants Living With Obesity or Overweight With Co-morbidity (ASCEND)

Active, not recruiting

Apr 202545 participants

A Modular Phase 2, Single-arm, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of AZD0486 in Participants With Relapsed or Refractory (R/R) B-cell Non-Hodgkin Lymphoma

Jan 202520 participants

COMPASS study (COMPASS study)

Active, not recruiting

Dec 2024200 participants

A Phase IIb, Randomized, Double-blind, Placebo-controlled and Open-label Active Comparator Study to Evaluate the Efficacy, Safety, and Tolerability of AZD5004 in Adults With Type 2 Diabetes Mellitus.

Nov 202428 participants

Effects of AZD5004 in adults who are living with obesity or overweight with at least 1 weight-related comorbidity (VISTA)

Active, not recruiting

Nov 202419 participants

A Phase I Double-blind, Placebo-controlled Study to Evaluate theSafety, Tolerability and Pharmacokinetics of AZD5148 in HealthyJapanese Adults

Active, not recruiting

Oct 202416 participants

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung15)

Oct 202477 participants

A Phase I, Multicentre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of AZD1390 in Combination With Radiation Therapy in Patients With Glioblastoma Multiforme and Brain Metastases From Solid Tumors.

Sep 202418 participants

Page 1 of 23

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials181
Approvals
News

Back to Organizations